Project Grant R01DA062642
- Federal Grant Award Summary The National Institute on Drug Abuse awarded The Johns Hopkins University a Project Grant of $1,541,806 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective August 1, 2025 through April 30, 2030. The STRONG (Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV) study will characterize opioid use disorder (OUD) treatment patterns and outcomes among people with HIV (PWH) by...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $197,624 Project Grant effective April 15, 2026 through March 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). Dr. Lauren Dayton's K01 Career Development Award will support an exploratory sequential mixed-methods research study examining how social networks influence medication for opioid use disorder (MOUD) engagement among parents who misuse...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded The Johns Hopkins University a $232,625 Project Grant effective September 15, 2025, through August 31, 2027. This research initiative examines co-infection patterns of HIV, hepatitis C, and sexually transmitted infections (syphilis, gonorrhea, and chlamydia) among people who inject drugs (PWID) in Cabell County, West Virginia, where an ongoing HIV...
- Federal Grant Award Summary The Johns Hopkins University received a $182,187 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), effective August 1, 2025 through July 31, 2030. This award supports a five-year research initiative examining spatial access to medications for opioid use disorder (MOUD), specifically buprenorphine and methadone, when co-located with mental health services. The research addresses a critical...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a Project Grant totaling $865,823 under the Drug Use and Addiction Research Programs (CFDA 93.279) on June 15, 2026, with a completion date of March 31, 2031. This research grant supports a multidisciplinary investigation into the immune mechanisms that impact blood-brain barrier (BBB) integrity in people who inject drugs (PWID), with and without HIV infection. The primary...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $1,445,834 Project Grant on September 15, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate a novel approach to dispensing methadone in carceral facilities. This mixed-methods research initiative addresses the critical gap in medication for opioid use disorder (MOUD) access within incarcerated populations by leveraging a 2024 Substance Abuse and Mental...
- Federal Grant Award Summary The Johns Hopkins University received a $198,164 Project Grant from the National Institute on Drug Abuse under the Drug Use and Addiction Research Programs (CFDA 93.279) awarded October 17, 2025, with completion by May 14, 2027. The project, titled "Improving Access and Linkage to Substance Use Treatment for Formerly Incarcerated Persons Applying a Complex Systems Approach," delivers research and analysis services focused on enhancing access to Medications...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $466,363 Project Grant effective June 1, 2026 through April 30, 2031 under the Drug Use and Addiction Research Programs (CFDA 93.279). This award supports fundamental research to characterize and exploit allosteric crosstalk among pain receptors, specifically examining how endogenous neuromodulators such as endocannabinoids and oxytocin allosterically modulate mu-opioid receptor (MOR)...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a $439,180 Project Grant effective September 1, 2025, through August 31, 2027, under the Drug Use and Addiction Research Programs (CFDA 93.279). This R21 exploratory/developmental grant supports research investigating dopaminergic neuronal-glial interactions in the striatum, with specific focus on understanding how HIV replication and methamphetamine exposure alter communication between...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $465,250 Project Grant to The Johns Hopkins University effective September 1, 2025 through August 31, 2027 under the Drug Use and Addiction Research Programs (CFDA 93.279). This research project will conduct a human laboratory study to assess pregnenolone, a negative allosteric modulator (NAM) of the CB1 cannabinoid receptor, as a potential treatment for cannabis intoxication symptoms. The study will employ a...
The National Institute on Drug Abuse (NIDA) awarded The Johns Hopkins University a Project Grant totaling $686,170 (Award Date: June 15, 2026; Completion Date: March 31, 2031) under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and evaluate the Better Together (BT) intervention. The BT intervention is an 8-session, age-appropriate selective prevention program designed to prevent substance use among adolescents ages 11 to 13 who are exposed to household challenges (parental substance use, incarceration, and mental health issues) and negative neighborhood contexts (violence and low social cohesion). The program was developed in partnership with affected families and incorporates their lived experiences, addressing gaps in existing prevention approaches by enhancing internal and external assets and fostering social connections. The research team, led by Principal Investigator Powell, proposes a hybrid Type 1 study to evaluate the BT intervention's efficacy in preventing drug use and reducing consequences among vulnerable youth populations. Prior to this award, qualitative and quantitative findings from process evaluations and pilot studies demonstrated that BT is acceptable, feasible, and capable of successfully recruiting, retaining, and engaging the target population. The funded project will continue the systematic evaluation of this promising intervention strategy, contributing to the evidence base for substance use prevention among youth experiencing compounded risk factors at the intersection of household and neighborhood disadvantage.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $686.2k | 6/9/26 |